Cwiertka Karel Ph.D.

Cwiertka Karel Ph.D.'s picture
Academic Title: MUDr.

Publications (Impact Factor Journals):

  • [13]
    MAJERA, D., Z. ŠKROTT, J. BOUCHAL, J. BARTKOVA, D. ŠIMKOVÁ, M. GACHECHILADZE, J. STEIGEROVÁ, D. KURFÜRSTOVÁ, J. GURSKÝ, G. KOŘÍNKOVÁ, K. CWIERTKA, Z. HODNY, M. MISTRÍK a J. BÁRTEK. Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. The Prostate. 2018, 79(4), 352-362. ISSN 0270-4137. IF: 3.347. PMID: 30499118
  • [12]
    HORAKOVA, D., K. BOUCHALOVÁ, K. CWIERTKA, L. STEPANEK, J. VLCKOVA a H. KOLLAROVA. Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2018, 162(2), 83-89. ISSN 1213-8118. IF: 0.894. PMID: 29765171
  • [11]
    MATZENAUER, M., D. VRÁNA, Z. VLACHOVA, K. CWIERTKA, O. KALITA a B. MELICHAR. Radiotherapy management of brain metastases using conventional linear accelerator. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2016, 160(3), 412-416. ISSN 1213-8118 . IF: 0.894. PMID: 27641139
  • [10]
    VRÁNA, D., H. ŠTUDENTOVÁ, M. MATZENAUER, Z. VLACHOVA, K. CWIERTKA, D. GREMLICA a O. KALITA. Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing. Oncology Letters. 2016, 11(6), 3777-3781. ISSN 1792-1074. IF: 1.390. PMID: 27313693
  • [9]
    ZEZULOVÁ, M., M. BARTOUŠKOVÁ, E. HLIDKOVA, J. JURANOVA, B. CERVINKOVA, E. KASALOVA, T. ADAM, L. KUJOVSKA KRCMOVA, D. SOLICHOVA, K. CWIERTKA, D. VRÁNA a B. MELICHAR. Prognostic significance of serum and urinary neopterin concentrations in patients with rectal carcinoma treated with chemoradiation. Anticancer Research . 2016, 36(1), 287-292. ISSN 0250-7005. IF: 1.937. PMID: 26722055
  • [8]
    ZEZULOVÁ, M., M. BARTOUŠKOVÁ, E. HLIDKOVA, T. ADAM, L. KUJOVSKA KRCMOVA, B. CERVINKOVA, D. SOLICHOVA, M. ZLEVOROVA, K. CWIERTKA, D. FRIEDECKÝ, D. VRÁNA a B. MELICHAR. Citrulline as a biomarker of gastrointestinal toxicity in patients with rectal carcinoma treated with chemoradiation. Clinical Chemistry and Laboratory Medicine . 2015, 54(2), 305-314. ISSN 1434-6621 . IF: 3.017. PMID: 26167980
  • [7]
    BOUCHALOVÁ, K., M. SVOBODA, G. KHARAISHVILI, J. VRBKOVÁ, J. BOUCHAL, R. TROJANEC, V. KOUDELÁKOVÁ, L. RADOVÁ, K. CWIERTKA, M. HAJDÚCH a Z. KOLÁŘ. BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy. Tumor Biology. 2015, 36(6), 4243-52. ISSN 1010-4283 . IF: 2.926. PMID: 25616695
  • [6]
    LUKESOVA, L., D. VRÁNA, J. GATEK, P.. KORANDA, K. CWIERTKA, L. RADOVÁ, B. MELICHAR, Z. PROUZOVÁ, V. ŠRÁMEK a I. SVACH. Predictive parameters for internal mammary node drainage in patients with early breast cancer. Tumori. 2014, 100(3), 254-258. ISSN 0300-8916. IF: 1.269. PMID: 25076234
  • [5]
    TOBIAS, P., D. VRÁNA, K. CWIERTKA, D. GREMLICA a P. SLAMPA. Significance of using DICOM communication standard in quality assurance in radiation oncology – an institutional experience. Journal of BUON. 2013, 18(4), 1045-1047. ISSN 1107-0625. IF: 0.706. PMID: 24344036
  • [4]
    VRÁNA, D., J. GATEK, K. CWIERTKA, L. LUKESOVA a P.. KORANDA. Internal mammary node management in breast cancer. A review. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2013, 157(3), 261-265. ISSN 1213-8118. IF: 1.661. PMID: 24042333
  • [3]
    ČÍŽKOVÁ, M., K. BOUCHALOVÁ, D. FRIEDECKÝ, A. POLYNKOVA, A. JANOŠŤÁKOVÁ, L. RADOVÁ, K. CWIERTKA, R. TROJANEC, M. ZEZULOVÁ, M. ZLEVOROVA, M. HAJDÚCH a B. MELICHAR. High lapatinib plasma levels in breast cancer patients: risk or benefit?. Tumori. 2012, 98(1), 162-165. ISSN 0300-8916. IF: 0.922. PMID: 22495718
  • [2]
    BOUCHALOVÁ, K., M. ČÍŽKOVÁ, K. CWIERTKA, R. TROJANEC, D. FRIEDECKÝ a M. HAJDÚCH. Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2010, 154(4), 281-288. ISSN 1213-8118. IF: 0.716. PMID: 21293538
  • [1]
    BOUCHALOVÁ, K., R. TROJANEC, Z. KOLÁŘ, K. CWIERTKA, I. ČERNÁKOVÁ, V. MIHÁL a M. HAJDÚCH. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer. Neoplasma. 2006, 53(5), 393-401. ISSN 0028-2685. IF: 0.731. PMID: 17013533

Publications (Other Reviewed Journals):

  • [1]
    KALITA, O., K. CWIERTKA, D. VRÁNA, M. VAVERKA, L. TUČKOVÁ a M. HOUDOVÁ MEGOVÁ . Multimodal Therapy of Recurrent Malignant Schwannoma. Klinická onkologie. 2016, 29(5), 364-368. ISSN 0862-495X.